Free Trial
OTCMKTS:BSEM

BioStem Technologies (BSEM) Stock Price, News & Analysis

BioStem Technologies logo
$8.20 +0.45 (+5.81%)
As of 04/2/2025 03:59 PM Eastern

About BioStem Technologies Stock (OTCMKTS:BSEM)

Key Stats

Today's Range
$6.95
$8.87
50-Day Range
$7.75
$18.60
52-Week Range
$6.77
$28.26
Volume
82,941 shs
Average Volume
60,249 shs
Market Capitalization
$136.97 million
P/E Ratio
12.06
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

Remove Ads
Receive BSEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioStem Technologies and its competitors with MarketBeat's FREE daily newsletter.

BSEM Stock News Headlines

DOGE tax surprise
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.
BSEM Continues to Excel
Biostem Technologies Inc
See More Headlines

BSEM Stock Analysis - Frequently Asked Questions

BioStem Technologies' stock was trading at $13.84 at the start of the year. Since then, BSEM shares have decreased by 40.8% and is now trading at $8.20.
View the best growth stocks for 2025 here
.

BioStem Technologies, Inc. (OTCMKTS:BSEM) posted its quarterly earnings results on Tuesday, November, 12th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.31 by $0.01. The company had revenue of $82.56 million for the quarter, compared to analyst estimates of $78.22 million.

Shares of BSEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioStem Technologies investors own include NVIDIA (NVDA), Tesla (TSLA), Broadcom (AVGO), Advanced Micro Devices (AMD), SoFi Technologies (SOFI) and Energy Transfer (ET).

Company Calendar

Last Earnings
11/12/2024
Today
4/03/2025
Next Earnings (Estimated)
4/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:BSEM
Previous Symbol
OTCMKTS:BSEM
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
12.06
Forward P/E Ratio
5.82
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$16.68 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$136.97 million
Optionable
N/A
Beta
-0.39
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:BSEM) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners